MedPath

A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease

Phase 2
Completed
Conditions
HIV Infections
Registration Number
NCT00000880
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Brief Summary

The purpose of this study is to determine the safety and effectiveness of low doses of cyclosporine (CsA) in patients with early HIV infection and to evaluate its effect on the immune system.

Activation of T cells (cells of the immune system) leads to HIV replication. Inhibition of immune activation is therefore a potentially important area of therapy for patients with early HIV infection. CsA is capable of decreasing T cell activation, which in turn may decrease HIV replication.

Detailed Description

There is increasing data on the potential for inhibition of immune activation as primary therapy for HIV infection. The rationale of CsA therapy is to decrease T cell activation in patients with early HIV infection. Activation of T cells leads to translation and transcription of provirus, release of viral progeny, and ultimately cell death. T cell activation also leads to increased cell death via apoptosis. CsA is capable of inhibiting both these events and thus may lead to decreased CD4 cell turnover.

This study has 2 arms of 15 patients each. Patients in Arm I receive placebo. Patients in Arm II receive CsA. Each arm is further divided into 2 strata. Stratum 1 patients are not allowed to receive antiretroviral therapy. Stratum 2 patients must receive 1 of the following 4 stable nucleoside analogue combinations:

1. Zidovudine (ZDV) plus lamivudine (3TC)

2. ZDV plus didanosine (ddI)

3. Stavudine (d4T) plus 3TC

4. d4T plus ddI.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (12)

Bellevue Hosp / New York Univ Med Ctr

🇺🇸

New York, New York, United States

Beth Israel Med Ctr

🇺🇸

New York, New York, United States

Univ of North Carolina

🇺🇸

Chapel Hill, North Carolina, United States

Harvard (Massachusetts Gen Hosp)

🇺🇸

Boston, Massachusetts, United States

Rush Presbyterian - Saint Luke's Med Ctr

🇺🇸

Chicago, Illinois, United States

Univ of Texas Med Branch

🇺🇸

Galveston, Texas, United States

San Francisco Gen Hosp

🇺🇸

San Francisco, California, United States

Univ of Colorado Health Sciences Ctr

🇺🇸

Denver, Colorado, United States

Northwestern Univ Med School

🇺🇸

Chicago, Illinois, United States

Johns Hopkins Hosp

🇺🇸

Baltimore, Maryland, United States

Case Western Reserve Univ

🇺🇸

Cleveland, Ohio, United States

Univ of Washington

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath